187 related articles for article (PubMed ID: 34771607)
1. Single-Cell Proteomic Analysis Dissects the Complexity of Tumor Microenvironment in Muscle Invasive Bladder Cancer.
Feng C; Wang X; Tao Y; Xie Y; Lai Z; Li Z; Hu J; Tang S; Pan L; He L; Wang Q; Li T; Mo Z
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771607
[TBL] [Abstract][Full Text] [Related]
2. Tumour microenvironment (TME) characterization identified prognosis and immunotherapy response in muscle-invasive bladder cancer (MIBC).
Cao R; Yuan L; Ma B; Wang G; Tian Y
Cancer Immunol Immunother; 2021 Jan; 70(1):1-18. PubMed ID: 32617668
[TBL] [Abstract][Full Text] [Related]
3. Identification of prognostic biomarkers associated with stromal cell infiltration in muscle-invasive bladder cancer by bioinformatics analyses.
Li P; Cao J; Li J; Yao Z; Han D; Ying L; Wang Z; Tian J
Cancer Med; 2020 Oct; 9(19):7253-7267. PubMed ID: 32786144
[TBL] [Abstract][Full Text] [Related]
4. Tumor heterogeneity in muscle-invasive bladder cancer.
Kang HW; Kim WJ; Choi W; Yun SJ
Transl Androl Urol; 2020 Dec; 9(6):2866-2880. PubMed ID: 33457261
[TBL] [Abstract][Full Text] [Related]
5. A combination of ssGSEA and mass cytometry identifies immune microenvironment in muscle-invasive bladder cancer.
Wang X; Pan L; Lu Q; Huang H; Feng C; Tao Y; Li Z; Hu J; Lai Z; Wang Q; Tang Z; Xie Y; Li T
J Clin Lab Anal; 2021 May; 35(5):e23754. PubMed ID: 33813769
[TBL] [Abstract][Full Text] [Related]
6. Identification and Immunocorrelation of Prognosis-Related Genes Associated With Development of Muscle-Invasive Bladder Cancer.
Li J; Lou Y; Li S; Sheng F; Liu S; Du E; Zhang Z
Front Mol Biosci; 2020; 7():598599. PubMed ID: 33604353
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of poor prognosis immunoevasive subtype of muscle-invasive bladder cancer with tumor-infiltrating podoplanin
Zhou Q; Wang Z; Zeng H; Zhang H; Liu Z; Huang Q; Wang J; Chang Y; Bai Q; Liu L; Zhu Y; Xu L; Dai B; Guo J; Xia Y; Wang Y; Xu J
Oncoimmunology; 2020 Apr; 9(1):1747333. PubMed ID: 33457092
[TBL] [Abstract][Full Text] [Related]
8. New horizons in bladder cancer research.
Boormans JL; Zwarthoff EC; Black PC; Goebell PJ; Kamat AM; Nawroth R; Seiler R; Williams SB; Schmitz-Dräger BJ
Urol Oncol; 2020 Dec; 38(12):867-885. PubMed ID: 30852032
[TBL] [Abstract][Full Text] [Related]
9. Classification of Muscle-Invasive Bladder Cancer Based on Immunogenomic Profiling.
Zhou X; Qiu S; Nie L; Jin D; Jin K; Zheng X; Yang L; Wei Q
Front Oncol; 2020; 10():1429. PubMed ID: 32974156
[TBL] [Abstract][Full Text] [Related]
10. Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients.
Weyerer V; Strissel PL; Strick R; Sikic D; Geppert CI; Bertz S; Lange F; Taubert H; Wach S; Breyer J; Bolenz C; Erben P; Schmitz-Draeger BJ; Wullich B; Hartmann A; Eckstein M
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34066058
[TBL] [Abstract][Full Text] [Related]
11. An immune relevant signature for predicting prognoses and immunotherapeutic responses in patients with muscle-invasive bladder cancer (MIBC).
Jiang W; Zhu D; Wang C; Zhu Y
Cancer Med; 2020 Apr; 9(8):2774-2790. PubMed ID: 32096345
[TBL] [Abstract][Full Text] [Related]
12. Mapping the tumor microenvironment in bladder cancer and exploring the prognostic genes by single-cell RNA sequencing.
Chen Z; Chen D; Song Z; Lv Y; Qi D
Front Oncol; 2022; 12():1105026. PubMed ID: 36741702
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of tumor-infiltrating immune cells in muscle-invasive bladder cancer.
Peng YL; Wu ZS; Lu HM; Wei WS; Xiong LB; Yu CP; Liu ZF; Li XD; Jiang LJ; Li YH; Liu ZW; Zhang ZL; Zhou FJ
Am J Transl Res; 2020; 12(10):6524-6536. PubMed ID: 33194049
[TBL] [Abstract][Full Text] [Related]
14. Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer.
Efstathiou JA; Mouw KW; Gibb EA; Liu Y; Wu CL; Drumm MR; da Costa JB; du Plessis M; Wang NQ; Davicioni E; Feng FY; Seiler R; Black PC; Shipley WU; Miyamoto DT
Eur Urol; 2019 Jul; 76(1):59-68. PubMed ID: 30712971
[TBL] [Abstract][Full Text] [Related]
15. Poor clinical outcomes and immunoevasive contexture in interleukin-9 abundant muscle-invasive bladder cancer.
Zhou Q; Zhang H; Wang Z; Zeng H; Liu Z; Huang Q; Lin Z; Qu Y; Xiong Y; Wang J; Chang Y; Bai Q; Xia Y; Wang Y; Liu L; Dai B; Guo J; Zhu Y; Xu L; Xu J
Int J Cancer; 2020 Dec; 147(12):3539-3549. PubMed ID: 32734613
[TBL] [Abstract][Full Text] [Related]
16. Blockade of DC-SIGN
Hu B; Wang Z; Zeng H; Qi Y; Chen Y; Wang T; Wang J; Chang Y; Bai Q; Xia Y; Wang Y; Liu L; Zhu Y; Dai B; Guo J; Xu L; Zhang W; Xu J
Cancer Res; 2020 Apr; 80(8):1707-1719. PubMed ID: 32060149
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Immunological Features in Muscle-Invasive Bladder Cancer Prognosis Using Ensemble Learning.
Gavriel CG; Dimitriou N; Brieu N; Nearchou IP; Arandjelović O; Schmidt G; Harrison DJ; Caie PD
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33915698
[TBL] [Abstract][Full Text] [Related]
18. Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics.
Costa C; Pereira S; Lima L; Peixoto A; Fernandes E; Neves D; Neves M; Gaiteiro C; Tavares A; Gil da Costa RM; Cruz R; Amaro T; Oliveira PA; Ferreira JA; Santos LL
PLoS One; 2015; 10(11):e0141253. PubMed ID: 26569621
[TBL] [Abstract][Full Text] [Related]
19. Integrative Transcriptomic, Lipidomic, and Metabolomic Analysis Reveals Potential Biomarkers of Basal and Luminal Muscle Invasive Bladder Cancer Subtypes.
Feng C; Pan L; Tang S; He L; Wang X; Tao Y; Xie Y; Lai Z; Tang Z; Wang Q; Li T
Front Genet; 2021; 12():695662. PubMed ID: 34484294
[TBL] [Abstract][Full Text] [Related]
20. PD-1-Positive Tumor-Associated Macrophages Define Poor Clinical Outcomes in Patients With Muscle Invasive Bladder Cancer Through Potential CD68/PD-1 Complex Interactions.
Jiang LR; Zhang N; Chen ST; He J; Liu YH; Han YQ; Shi XQ; Yang JJ; Mu DY; Fu GH; Gao F
Front Oncol; 2021; 11():679928. PubMed ID: 34079767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
